MAR 28, 2019 7:30 AM PDT

Keynote Presentation: Cannabis for Mental Health: What Consumers Need to Know

C.E. Credits: P.A.C.E. CE Florida CE
  • CEO, Director of Translational Research, International Research Center on Cannabis and Mental Health
      Jan Roberts is a recognized leader in the field of cannabis and mental health. Ms. Roberts is
      a licensed clinical social worker and the Chief Executive Officer and Director of Translational Research at the International Research Center on Cannabis and Mental Health, a collaborative research institute located in New York that bridges university and community-based projects. In addition, Ms. Roberts is the founder and CEO of Partners in Health and Wellbeing, one of the largest multi-site mental health and wellness practices in the mid-Atlantic region in the United States. Ms. Roberts teaches at the NYU Silver School of Social Work, where she will be awarded her doctorate in May 2019, and at CUNY Hunter College's Silberman School of Social Work. In addition, Ms. Roberts is a governor-appointed member on the Delaware Medical Marijuana Act Advisory Committee and is the current Guest Editor for the Clinical Social Work Journal's upcoming special issue on cannabis and mental health. Ms. Roberts lives in New York and sees patients at her practice in Manhattan.


    The endocannabinoid system (ECS) is a physiological system that occurs within all mammals and is responsible for maintaining homeostasis and keeping the body in a state of wellbeing, helping us to “eat, sleep, relax and forget” (Americans for Safe Access, 2017; Pettinato, 2017). Initially, most research into the endocannabinoid system was focused on the mechanisms that affect physical health (Martin, 1991). However, there is a growing body of research demonstrating the role that the endocannabinoid system plays in mental health and mood regulation (Walsh et al. 2017). As a result, mental health clinicians often do not have a clear understanding of what the endocannabinoid system is, how it can affect moods, and how exogenous cannabinoids such as cannabis can affect moods, emotions, and related conditions (Feingold, Weiser, Rehm & Lev-Ran, 2015). The purpose of this presentation is to provide a brief overview of the endocannabinoid system, current research on exogenous cannabinoids’ impact on mood regulation, and the potential positive therapeutic impacts of cannabis on mental health and implications for clinical practice. 

    Learning Objectives: 

    1. Participants will understand the role that the endocannabinoid system can have impacting mood.
    2. Participants will how mental health conditions may be positively impacted by cannabis.


    Show Resources
    Show Resources
    • See more